A case report of very late stent thrombosis with peri-stent coronary artery aneurysm and stent-related coronary vasospasm

Cardiovascular Intervention and Therapeutics

Volumn 28, Issue 3, 2013, Pages 272-278

  Takeda, Morihiko ^a,b   Shiba, Nobuyuki ^a   Takahashi, Jun ^b   Shimokawa, Hiroaki ^b  

^a International University of Health and Welfare Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery aneurysm; Coronary vasospasm; Fasudil; Rho kinase; Very late stent thrombosis

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BENIDIPINE; FASUDIL; ISOSORBIDE DINITRATE; NICORANDIL; TICLOPIDINE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ANTERIOR MYOCARDIAL INFARCTION; ANTICOAGULANT THERAPY; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; CASE REPORT; CORONARY ARTERY ANEURYSM; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY SPASM; ELECTROCARDIOGRAPHY; FOLLOW UP; GASTRITIS; HEART VENTRICLE FIBRILLATION; HOSPITALIZATION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MEDICAL HISTORY; OPTICAL COHERENCE TOMOGRAPHY; OUT OF HOSPITAL CARDIAC ARREST; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROVOCATION TEST; RESUSCITATION; STENT THROMBOSIS; THORAX PAIN; THROMBUS ASPIRATION; TREATMENT DURATION; VASOCONSTRICTION; VASOMOTOR REFLEX; VERY LATE STENT THROMBOSIS;

ADULT; CORONARY ANEURYSM; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VASOSPASM; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; SIROLIMUS; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84880141398     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-012-0155-7     Document Type: Article

References (16)

1. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115: 1440-55.
2. Stabile E, Escolar E, Weigold G, Weissman NJ, Satler LF, Pichard AD, et al. Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation. Circulation. 2004;110: e47-8.
3. Brott BC, Anayiotos AS, Chapman GD, Anderson PG, Hillegass WB. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol. 2006;18: 584-92.
4. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2005;27: 166-70.
5. Aizawa K, Yasuda S, Takahashi J, Takii T, Kikuchi Y, Tsuburaya R, et al. Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease. Circ J. 2012;76: 2552-60.
6. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115: 1051-8.
7. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109: 701-5.
8. Pendyala LK, Yin LJ, Chen JP, Chronos N, Hou D. The first-generation drug-eluting stents and coronary endothelial dysfunction. J Am Coll Cardiol Intv. 2009;2: 1169-77.
9. Shiroto T, Yasuda S, Tsuburaya R, Ito Y, Takahashi J, Ito K, et al. Role of rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. J Am Coll Cardiol. 2009;54: 2321-9.
10. Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002;106: 57-62.
11. Hiroki J, Shimokawa H, Higashi M, Morikawa K, Kandabashi T, Kawamura N, et al. Inflammatory stimuli upregulate rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol. 2004;37: 537-46.
12. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31: 1470-6.
13. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, et al. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011;123: 2382-91.
14. Kon H, Sakai H, Otsubo M, Takano H, Okamoto K, Sato T, et al. Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. Circ Cardiovasc Interv. 2011;4: e1-3.
15. Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, et al. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. J Am Coll Cardiol. 2009;53: 1653-9.
16. Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1: 193-200.